Status:
COMPLETED
Effect of CGF on Postoperative Pain After Third Molar Surgery
Lead Sponsor:
Ege University
Conditions:
Oral Complication
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effects of concentrated growth factor (CGF) on pain after bilateral impacted third molar surgery and to determine its contribution to the healing process. ...
Eligibility Criteria
Inclusion
- Patients with bilateral, symmetrical, bone-retained (vertical, mesioangular, horizontal) impacted wisdom teeth in the mandible, regardless of gender
- Patients without any systemic disease
- Patients who have been informed about the duration, purpose and requirements of the study and who have signed the informed consent form voluntarily.
Exclusion
- Having a disease affecting general health that requires the application of prophylactic antimicrobial agents
- Having a systemic viral, fungal or bacterial infection
- Patients with acute or chronic maxillary sinusitis
- Suspected or diagnosed pregnancy and nursing mothers
- Patients with heart and vascular diseases
- Patients with liver disease, haematological disease and neoplastic disease
- Patients who have recently received anti-inflammatory therapy
- Patients with chronic medication use (antihistamines, NSAIDs, steroids and antidepressants)
- Patients predisposed to psychotic or psychopathic tendencies
- Patients with rheumatic diseases, blood diseases, diabetes mellitus
- Patients at cardiological risk of infective endocarditis
- Patients under antibiotic pressure
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2018
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT06918327
Start Date
May 1 2017
End Date
June 5 2018
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University Faculty of Dentistry
Izmir, Bornova, Turkey (Türkiye), 35040